Barclay A Phillips insider trades

Open-market stock purchases and sales by Barclay A Phillips, Director at Immunic, Inc, from SEC Form 4 filings since Jan 29, 2010.

Track record: 100% of 5 scored buys are up 5% or more since purchase, averaging +135%.

Recent trades

DateStockTradeValue
Jul 5, 2026IMUX Immunic, IncBought (not open market)—
Jun 29, 2026IMUX Immunic, IncBought (not open market)—

Companies traded

  • IMUX Immunic, Inc: other filings, last Jul 5, 2026
  • GTHX G1 Therapeutics, Inc: 1 sale, last Nov 15, 2018
  • NVAX Novavax Inc: 14 buys, 2 sales, last Jul 31, 2017
  • MITI Micromet, Inc: other filings, last Mar 7, 2012

Get free alerts when Barclay A Phillips files a new trade →